Moreover, thymus and activation-regulated chemokine (TARC) and interleukin 1 β (IL-1β) levels in the plasma tended to be increased in patients with SSc-ILD and AAV-ILD, respectively. This evidence concerns the gene IL1B and systemic sclerosis.